JPRN-UMIN000004647已完成2 期
Phase II clinical trial of third-line Panitumumab and irinotecan or Panitumumab therapy for patients with KRAS wild-type unresectable/recurrent colorectal cancer - SHIP trial: Short-time Infusion of Panitumumab feasibility
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) other active malignancies within 5 years 2) history of severe drug hypersensitivity 3) clinically significant infectious disease (body temperature less than 38.0 degrees) 4) severe complications (ileus, bowel obstruction, interstitial lung disease, pulmonary fibrosis, uncontrolled diabetes mellitus, heart failure, renal failure, hepatic failure, etc.) 5) patients who have abnormal findings on ECG and need any treatment (within 4 weeks before registration) 6) moderate/severe pleural effusion or ascites 7) symptomatic brain metastasis 8) patients who need transfusion because of GI bleeding 9) uncontrolled watery diarrhea (watery colostomy output without trouble during patient's daily living is allowed) 10) pregnant or lactating women, women who are capable of pregnancy or intend to get pregnant, men who do not intend to have protected intercourse 11) any other cases who are regarded as unsuitable for enrollment in the study by the investigator
研究者
相似试验
进行中（未招募）
不适用
Estudio clínico abierto de fase II de panitumumab en combinación con quimioterapiaFOLFIRI como tratamiento de segunda línea en sujetos con cáncer colorrectalmetastásico que expresa KRAS no mutado y que haya progresado ≥ 6 meses despuésde la última dosis de la quimioterapia de primera línea - ACTIVECáncer colorrectal metastásico que expresa KRAS no mutadoEUCTR2009-010975-26-ESAssociació Catalana per a la Recerca Oncológica i les seves implicacions Sanitáries i Socials
进行中（未招募）
不适用
A Phase II Clinical Trial of Panitumumab in Combination with Infusional Oxaliplatin and Oral Capecitabine (XELOX) Chemotherapy as 1st line Therapy in Patients with Colorectal Cancer and Advanced Liver Metastases - NDPreviously untreated Patients with Colorectal Cancer and Advanced Liver Metastases.MedDRA version: 9.1Level: LLTClassification code 10052358Term: Colorectal cancer metastaticEUCTR2007-002007-41-ITAZIENDA OSPEDALIERA ORDINE MAURIZIANO
进行中（未招募）
不适用
An Phase 2 Clinical Trial of Panitumumab in Conbination vith Irinotecan chemotherapy as 2nd line Therapy in subjects with Metastatic Colorectal Cancer.Ensayo Clínico fase II de Panitumumab combinado con quimioterapia de Irinotecan como tratamiento de segunda linea en sujetos con cáncer colorectal metastásico.EUCTR2006-006363-24-ESGrupo de Tratamiento de los Tumores Digestivos (TTD)80
已完成
不适用
Phase II crinical trial of panitumumab rechallenge with KRAS wild-type unresectable/recurrent colorectal cancer.Colorectal CancerJPRN-UMIN000010954Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences25
招募中
2 期
Multicenter phase II trial of panitumumab plus irinotecan and S-1 (PIRIS regimen) in patients treated by oxaliplatin-based chemotherapy with K-RAS wild-type advanced colorectal cancer.Colorectal CancerJPRN-UMIN000004574Showa University Nothern Yokohama Hospital48